Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2020 Jul;24(7):622-629.
doi: 10.1007/s10157-020-01875-y. Epub 2020 Mar 22.

Efficacy of body weight vs body surface area-based prednisolone regimen in nephrotic syndrome

Biswanath Basu #  1 , Suman Bhattacharyya #  2 , Shilpita Barua  2 , Abhisek Naskar  2 , Birendranath Roy  2
Affiliations
Randomized Controlled Trial

Efficacy of body weight vs body surface area-based prednisolone regimen in nephrotic syndrome

Biswanath Basu et al. Clin Exp Nephrol. 2020 Jul.

Abstract

Background: Prednisolone dosing regimen based on body surface area (BSA) or body weight (BW) in managing uncomplicated nephrotic syndrome (NS) has been a matter of controversy.

Methods: In this parallel-arm randomized clinical trial, 60 children with uncomplicated NS in relapse were randomized to receive either of two regimens. Children of BW cohort received prednisolone (2 mg/kg/day) till remission (or 6 weeks for first episode); followed by 1.5 mg/kg on alternate days for 4 weeks (or 6 weeks for first episode). Children randomized for BSA cohort received prednisolone (60 mg/m2/day) till remission (or 6 week for first episode); followed by 40 mg/m2 on alternate days for 4 weeks (or 6 weeks for first episode). The primary endpoint was 6-month relapse-free survival in the intention-to-treat population (clinical trial registry of India CTRI/2015/03/005655).

Results: The 6-month relapse-free survival rates were similar for both BSA cohort 73.33% (22/30) and BW cohort 70% (21/30) (p = 1, OR 0.19, 95% CI 0.07-0.52). Requirement of cumulative steroid to achieve initial remission (96.1 ± 57.8 vs 63.58 ± 40.2 mg/kg, p = 0.014) and over 6-month study period (104.34 ± 50.82 vs 73.88 ± 42.95 mg/kg, p = 0.015) were significantly higher in BSA cohort in comparison to BW cohort. However, time taken in achieving remission during enrolment episode in both BSA and BW groups was comparable (7 ± 1.7 vs 6.9 ± 1.4 days, p = 0.81). While both treatments were well tolerated, the number of adverse events was one and half times as common in the BSA group than BW group (37 vs. 22 events).

Conclusions: In treating children with uncomplicated NS, both BSA and BW regimens were equally effective in achieving initial remission and maintaining disease remission. Due to fewer adverse events and lesser cumulative steroid exposure with BW based regimen, it may be considered as better option over BSA regimen.

Clinical trial registry name: Clinical Trial Registry of India (CTRI/2015/03/005655).

Keywords: Nephrotic syndrome; Pediatrics; Prednisolone.

PubMed Disclaimer

References

    1. Barnett HL. Nephrotic syndrome in children: a randomized trial comparing two prednisone regimens in steroid-responsive patients who relapse early. Report of the international study of kidney disease in children. J Pediatr. 1979;95:228–33. - DOI
    1. Gordillo R, Spitzer A. The nephrotic syndrome. Pediatr Rev. 2009;30:94. - DOI
    1. Consensus Statement of Management of Steroid Sensitive Nephrotic Syndrome. Indian Pediatric Nephrology Group, Indian Academy of Pediatrics. Indian Pediatr 2008;45:203–14.
    1. Niaudet P. long term outcome of children with steroid sensitive idiopathic nephrotic syndrome. CJASN. 2009;4(10):1547–8. - DOI
    1. Feber J, Al-Matrafi J, Farhadi E, et al. Prednisone dosing per body weight or body surface area in children with nephrotic syndrome—is it equivalent? Pediatr Nephrol. 2009;24:1027–31. - DOI

Publication types

LinkOut - more resources